Edition:
United Kingdom

Knight Therapeutics Inc (GUD.TO)

GUD.TO on Toronto Stock Exchange

7.44CAD
21 May 2019
Change (% chg)

$-0.02 (-0.27%)
Prev Close
$7.46
Open
$7.44
Day's High
$7.50
Day's Low
$7.37
Volume
268,484
Avg. Vol
358,857
52-wk High
$8.81
52-wk Low
$7.10

Latest Key Developments (Source: Significant Developments)

Knight Therapeutics Reports Q1 Basic EPS Of $0.04
Thursday, 9 May 2019 

May 9 (Reuters) - Knight Therapeutics Inc ::KNIGHT REPORTS FIRST QUARTER 2019 RESULTS.KNIGHT THERAPEUTICS INC QUARTERLY BASIC EARNINGS PER SHARE $0.04.KNIGHT THERAPEUTICS INC QUARTERLY REVENUES $2.96 MILLION VERSUS $3.15 MILLION.  Full Article

Medison Biotech - Co, Together With Affiliates Owns More Than 10.4 Million Shares Or 7.3% Of Knight Therapeutics
Friday, 3 May 2019 

May 3 (Reuters) - Knight Therapeutics Inc ::MEDISON BIOTECH - CO, TOGETHER WITH AFFILIATES OWNS MORE THAN 10.4 MILLION SHARES OR 7.3% OF KNIGHT THERAPEUTICS.MEDISON BIOTECH - MEDISON PLEDGES TO PURSUE ITS DIAMOND STRATEGY IN CANADA INDEPENDENTLY.MEDISON BIOTECH - "REMAINS COMMITTED TO ONGOING ENGAGEMENT WITH SHAREHOLDERS TO BRING NECESSARY CHANGE TO KNIGHT, INCLUDING AT VERY NEXT OPPORTUNITY".  Full Article

Medison Biotech Ltd Says Released Correspondence It Got From Knight's Lawyers And Accountants
Friday, 15 Mar 2019 

March 15 (Reuters) - Knight Therapeutics Inc ::MEDISON BIOTECH LTD - RELEASED CORRESPONDENCE IT GOT FROM KNIGHT'S LAWYERS AND ACCOUNTANTS.  Full Article

Medison Biotech Sends Open Letter To Knight Therapeutics Board
Thursday, 28 Feb 2019 

Feb 28 (Reuters) - Medison Biotech Ltd::SENT AN OPEN LETTER TO KNIGHT THERAPEUTICS'S BOARD.SAYS BOARD SHOULD INSIST JONATHAN GOODMAN RELINQUISH HIS ROLE AT KNIGHT THERAPEUTICS OR HIS FINANCIAL STAKE IN COMPETING FAMILY BUSINESS.SAYS TOGETHER WITH ITS AFFILIATES OWNS MORE THAN 10.4 MILLION SHARES, OR 7.3 PERCENT OF KNIGHT THERAPEUTICS.  Full Article

Knight Therapeutics QTRLY Basic Earnings Per Share $0.091
Thursday, 8 Nov 2018 

Nov 8 (Reuters) - Knight Therapeutics Inc ::KNIGHT THERAPEUTICS REPORTS THIRD QUARTER 2018 RESULTS.KNIGHT THERAPEUTICS INC - QTRLY BASIC EARNINGS PER SHARE $0.091.KNIGHT THERAPEUTICS INC - QTRLY REVENUES $3.2 MILLION VERSUS $1.9 MILLION.  Full Article

Knight Therapeutics Says ‍Will Have Exclusive Rights To Market And Sell Tenapanor In Canada​
Monday, 19 Mar 2018 

March 19 (Reuters) - Ardelyx Inc ::KNIGHT THERAPEUTICS - ‍LICENSE AGREEMENT WITH ARDELYX THAT PROVIDES KNIGHT WITH EXCLUSIVE RIGHTS TO COMMERCIALIZE TENAPANOR IN CANADA​.KNIGHT THERAPEUTICS - ‍WILL PAY UP TO C$25 MILLION IN TOTAL PAYMENTS INCLUDING AN UPFRONT PAYMENT AND DEVELOPMENT AND SALES MILESTONES.KNIGHT THERAPEUTICS INC - ‍KNIGHT WILL HAVE EXCLUSIVE RIGHTS TO MARKET AND SELL TENAPANOR IN CANADA​.  Full Article

Knight Reports Qtrly Basic Earnings Per Share $0.05
Thursday, 15 Mar 2018 

March 15 (Reuters) - Knight Therapeutics Inc ::KNIGHT REPORTS 2017 FOURTH QUARTER AND YEAR END RESULTS.QTRLY BASIC EARNINGS PER SHARE $0.05.QTRLY REVENUES $2.5 MILLION VERSUS $1.8 MILLION.Q4 EARNINGS PER SHARE VIEW C$0.04, REVENUE VIEW C$2.1 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Knight Therapeutics Says New Drug Submission For Netildex Accepted For Review By Health Canada​
Thursday, 15 Feb 2018 

Feb 15 (Reuters) - Knight Therapeutics Inc ::KNIGHT THERAPEUTICS AND SIFI S.P.A. ANNOUNCE FILING OF NEW DRUG SUBMISSION FOR NETILDEX IN CANADA.KNIGHT THERAPEUTICS INC - ‍KNIGHT'S NEW DRUG SUBMISSION FOR NETILDEX HAS BEEN ACCEPTED FOR REVIEW BY HEALTH CANADA​.  Full Article

KNIGHT THERAPEUTICS REPORTS Q3 EARNINGS PER SHARE $0.03
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Knight Therapeutics Inc :KNIGHT REPORTS THIRD QUARTER 2017 RESULTS.QTRLY ‍REVENUE $1.9 MILLION, A DECREASE OF 2 PERCENT​.QTRLY EARNINGS PER SHARE $0.03‍​.‍ALL CURRENCIES ARE CANADIAN​.  Full Article

Knight Therapeutics reports qtrly earnings per share $0.03‍​
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Knight Therapeutics Inc ::Knight reports third quarter 2017 results.Qtrly earnings per share $0.03.Q3 earnings per share view C$0.03 -- Thomson Reuters I/B/E/S‍​.Qtrly ‍revenues were $1.9 million, a decrease of 2 percent versus same period in prior year​.All currencies are Canadian‍​.  Full Article

CANADA STOCKS-TSX edges higher on robust earnings, energy rebound

May 8 Canada's main stock index rose on Wednesday, after two sessions of declines, as positive earnings and a rebound in energy stocks buoyed sentiment with focus on a crucial round of trade talks between the United States and China.